Authors: Levy, V Porcher, R Leblond, V Fermand, JP Cazin, B Maloisel, F Harousseau, JL Remenieras, L Guibon, O Chevret, S

Citation: V. Levy et al., Evaluating treatment strategies in advanced Waldenstrom macroglobulinemia:use of quality-adjusted survival analysis, LEUKEMIA, 15(9), 2001, pp. 1466-1470

Authors: Leblond, V Levy, V Maloisel, F Cazin, B Fermand, JP Harousseau, JL Remenieras, L Porcher, R Gardembas, M Marit, G Deconinck, E Desablens, B Guilhot, F Philippe, G Stamatoullas, A Guibon, O

Citation: V. Leblond et al., Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease, BLOOD, 98(9), 2001, pp. 2640-2644

Authors: Leporrier, M Chevret, S Cazin, B Boudjerra, N Feugier, P Desablens, B Rapp, MJ Jaubert, J Autrand, C Divine, M Dreyfus, B Maloum, K Travade, P Dighiero, G Binet, JL Chastang, C

Citation: M. Leporrier et al., Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients, BLOOD, 98(8), 2001, pp. 2319-2325

Authors: Dearden, CE Matutes, E Cazin, B Tjonnfjord, GE Parreira, A Nomdedeu, B Leoni, P Clark, FJ Radia, D Rassam, SMB Roques, T Ketterer, N Brito-Babapulle, V Dyer, MJS Catovsky, D

Citation: Ce. Dearden et al., High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, BLOOD, 98(6), 2001, pp. 1721-1726

Authors: Magnac, C Sutton, L Cazin, B Laurent, C Binet, JL Merle-Beral, H Dighiero, G Maloum, K

Citation: C. Magnac et al., Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL), HEM CELL TH, 41(1), 1999, pp. 13-18